logo
Select company
Select metric
-7751.39%Operating Cash Flow Margin
VS
Market
2
Sector
6
Industry
11
History
5
$ 4.03Close
$ 1.96 - $ 4.21 52-Week Range
Ticker Information

Ticker

VTGN

Company Name

VISTAGEN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VISTAGEN THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VTGN - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -50.07M-7751.39%$ 646K
3/31/2025$ -42.1M-8661.93%$ 486K
12/31/2024$ -39.23M-5618.23%$ 698.3K
9/30/2024$ -33.49M-3824.08%$ 875.7K
6/30/2024$ -28.79M-2966.93%$ 970.4K
3/31/2024$ -25.81M-2426.03%$ 1.06M
12/31/2023$ -26.09M-2502.98%$ 1.04M
9/30/2023$ -31.49M-3884.82%$ 810.5K
6/30/2023$ -41.64M0%$ -359.7K
3/31/2023$ -49.72M0%$ -227.3K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VISTAGEN THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -2593.35%.
  • Over the past 5 years, VISTAGEN THERAPEUTICS INC's average OCF % has been -3582.35%.
  • The median OCF % for VISTAGEN THERAPEUTICS INC during this period was -2780.14%
  • VISTAGEN THERAPEUTICS INC reached its highest OCF % over the past 5 years at -1069.53%.
  • The lowest OCF % recorded by VISTAGEN THERAPEUTICS INC in the same timeframe -8661.93%

VISTAGEN THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
RNXT : RENOVORX INC -1556.95%BTAI : BIOXCEL THERAPEUTICS INC -6424.54%ABVC : ABVC BIOPHARMA INC -448.8%COYA : COYA THERAPEUTICS INC -3890.1%AVTX : AVALO THERAPEUTICS INC -10752.38%ZTEK : ZENTEK LTD -653%ENTX : ENTERA BIO LTD -4009.64%INO : INOVIO PHARMACEUTICALS INC -51987.6%RPTX : REPARE THERAPEUTICS INC -41335.2%LEXX : LEXARIA BIOSCIENCE CORP -1574.8%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for VISTAGEN THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -8.66M ] / Revenues [ $ 334K ]
(=) OCF % [ -2593.35% ]

VTGN - Operating Cash Flow Margin, Last 5 years

-8661.93%

Minimum

Mar 31, 2025

-1069.53%

Maximum

Jun 30, 2021

-3582.35%

Average

-2780.14%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%